Virtual press conference on recent advances in focused ultrasound
Ultrasound-Focused Media Event
Monday, October 24, 2022
12 p.m. to 1:30 p.m. ET
Book your place by clicking HERE.
Newswise—The 8e International Symposium on Focused Ultrasound – a four-day virtual and in-person hybrid event hosted in Bethesda, MD –, includes an interactive virtual press briefing featuring the most recent clinical and preclinical advances and emerging applications of focused ultrasound. Global experts will highlight the use of focused ultrasound – a non-invasive, therapeutic, revolutionary and highly disruptive technology – in cancer immunotherapy; neuromodulation for depression; and the treatment of pancreatic cancer, pediatric brain tumors, and twin-to-twin transfusion syndrome in fetal populations.
The briefing will be held via Zoom with pre-recorded presentations, followed by a live Q&A session.
Speakers and featured topics include:
- David Attali, MD, and Marion Plaze, MD, Ph.D., GHU Paris Psychiatrie Neurosciences, Paris, France, will discuss the use of neuromodulation to treat psychiatric disorders.
- Patrick Dillon, MD, The University of Virginia’s Division of Hematology/Oncology will discuss the world’s first focused ultrasound immuno-oncology center and the application of focused ultrasound in immunotherapy.
- Jae Young Lee, MD, Department of Radiology, Seoul National University College of Medicine, Seoul, Korea will describe the application of ultrasound imaging in pancreatic cancer.
- Christoph Lees, MD, and Caroline Shaw, MD, Imperial College Healthcare NHS Trust, London, UK, will speak on the use of high-intensity focused ultrasound in twin-to-twin transfusion syndrome.
- Cheng-Chia (Fred) Wu, MD, Ph.D., Columbia University’s Department of Radiation Oncology will discuss focused ultrasound to treat DIPG, a rare fatal brain tumor affecting children.
The Symposium, organized by the Focused Ultrasound Foundation, is the world’s leading forum for sharing the latest translational and clinical advances in focused ultrasound. The four-day event will highlight groundbreaking preclinical, translational and clinical research related to one of today’s most promising and innovative therapeutic technologies. This year, we are offering members of the media FREE REGISTRATION to attend the Symposium in person or virtually (please email Wes Myhre for code).
Note: You do not need a code to Register for the free media event.
About Focused Ultrasound
Focused ultrasound uses ultrasound energy guided by real-time imaging to treat deep body tissues without incisions or radiation. It is FDA approved in the United States to treat essential tremor, tremor-dominant Parkinson’s disease, uterine fibroids, pain from bone metastases, osteoid osteoma, and prostate. Dozens of additional indications are approved outside the United States. The technology is in various stages of research and development for more than 160 diseases, including Alzheimer’s disease and tumors of the brain, liver, breast and pancreas.
About the Focused Ultrasound Foundation
The Focused Ultrasound Foundation was created to improve the lives of millions of people around the world by accelerating the development of this non-invasive technology. The Foundation strives to pave the way for global adoption by organizing and funding research, fostering collaboration, and educating patients and professionals. Since its inception in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. For more information, visit http://www.fusfoundation.org.